{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:19:46Z","timestamp":1787649586988,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J011594"],"award-info":[{"award-number":["2023J011594"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbamcr.2026.120212","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:23:31Z","timestamp":1787034211000},"page":"120212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["LAPTM4B promotes gefitinib resistance and tumor stemness in non-small cell lung cancer by stabilizing RPS3 through inhibiting its ubiquitination"],"prefix":"10.1016","volume":"1873","author":[{"given":"Yu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Qiu","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbamcr.2026.120212_bb0005","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.gendis.2022.07.023","article-title":"Non-small cell lung carcinoma (NSCLC): implications on molecular pathology and advances in early diagnostics and therapeutics","volume":"10","author":"Padinharayil","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbamcr.2026.120212_bb0010","article-title":"Uniqueness of lung cancer in Southeast Asia","volume":"27","author":"Noronha","year":"2024","journal-title":"Lancet Reg. Health Southeast Asia"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120212_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-022-01391-4","article-title":"Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance","volume":"15","author":"Fu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.bbamcr.2026.120212_bb0020","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.21037\/tcr-23-956","article-title":"Clinical advances in EGFR-TKI combination therapy for EGFR-mutated NSCLC: a narrative review","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl. Cancer Res."},{"issue":"9","key":"10.1016\/j.bbamcr.2026.120212_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091515","article-title":"Non-small cell lung cancer with epidermal growth factor receptor (EGFR) common mutations: new strategies","volume":"17","author":"Stanzione","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.bbamcr.2026.120212_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052042","article-title":"Drug resistance in late-stage epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer patients after first-line treatment with tyrosine kinase inhibitors","volume":"26","author":"Lee","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120212_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-018-0777-1","article-title":"Management of acquired resistance to EGFR TKI\u2013targeted therapy in advanced non-small cell lung cancer","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamcr.2026.120212_bb0040","article-title":"The role and regulatory mechanism of lysosome associated protein transmembrane 4\u03b2 in tumors","volume":"15","author":"Yang","year":"2025","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120212_bb0045","article-title":"LAPTM4B enhances the stemness of CD133+ liver cancer stem-like cells via WNT\/\u03b2-catenin signaling","volume":"7","author":"Wang","year":"2024","journal-title":"JHEP Rep."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120212_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/CM9.0000000000001021","article-title":"Lysosomal-associated protein transmembrane-4 beta: a novel potential biomarker for cancer therapy with multiple functions","volume":"134","author":"Xu","year":"2020","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"9","key":"10.1016\/j.bbamcr.2026.120212_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092699","article-title":"RNA-binding proteins in cancer: functional and therapeutic perspectives","volume":"12","author":"Kang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120212_bb0060","article-title":"The role of RNA binding proteins in cancer biology: a focus on FMRP","volume":"12","author":"Jia","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbamcr.2026.120212_bb0065","article-title":"m6A reader IGF2BP3 contributes to gefitinib resistance in lung adenocarcinoma cells by modulating SNAI2 expression","volume":"38","author":"Takatsuka","year":"2025","journal-title":"Gene Rep."},{"issue":"7","key":"10.1016\/j.bbamcr.2026.120212_bb0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/1541-7786.MCR-11-0061","article-title":"SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells","volume":"9","author":"Shultz","year":"2011","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbamcr.2026.120212_bb0075","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1096\/fj.201903245R","article-title":"Ribosomal protein S3 is a novel negative regulator of non-homologous end joining repair of DNA double-strand breaks","volume":"34","author":"Park","year":"2020","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120212_bb0080","first-page":"1206","article-title":"Ribosomal protein S3 mediates drug resistance of proteasome inhibitor: potential therapeutic application in multiple myeloma","volume":"109","author":"Chen","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.bbamcr.2026.120212_bb0085","article-title":"Cisplatin-resistant gastric cancer cells promote the chemoresistance of cisplatin-sensitive cells via the exosomal RPS3-mediated PI3K-Akt-Cofilin-1 signaling axis","volume":"9","author":"Sun","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.bbamcr.2026.120212_bb0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41388-022-02581-7","article-title":"UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3","volume":"42","author":"Wang","year":"2023","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.bbamcr.2026.120212_bb0095","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.18632\/aging.204211","article-title":"SIAH1-mediated RPS3 ubiquitination contributes to chemosensitivity in epithelial ovarian cancer","volume":"14","author":"Chen","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbamcr.2026.120212_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1137384","article-title":"Monitoring EGFR-lung cancer evolution: a possible beginning of a \u201cmethylation era\u201d in TKI resistance prediction","volume":"13","author":"Fabrizio","year":"2023","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.bbamcr.2026.120212_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41419-024-06542-8","article-title":"LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bbamcr.2026.120212_bb0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3892\/ol.2021.13026","article-title":"LAPTM4B promotes the progression of bladder cancer by stimulating cell proliferation and invasion","volume":"22","author":"Yin","year":"2021","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.bbamcr.2026.120212_bb0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41419-024-06836-x","article-title":"LAPTM4B counteracts ferroptosis via suppressing the ubiquitin-proteasome degradation of SLC7A11 in non-small cell lung cancer","volume":"15","author":"Yan","year":"2024","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120212_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040976","article-title":"Dissecting tumor growth: the role of cancer stem cells in drug resistance and recurrence","volume":"14","author":"Aramini","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120212_bb0125","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12935-024-03558-0","article-title":"Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy","volume":"24","author":"Mengistu","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120212_bb0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/ot9.0000000000000028","article-title":"Research progress on lung cancer stem cells in epidermal growth factor receptor\u2013tyrosine kinase inhibitor targeted therapy resistance in lung adenocarcinoma","volume":"10","author":"Zhang","year":"2024","journal-title":"Oncol. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120212_bb0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.33549\/physiolres.935642","article-title":"RPS3 aggravates sepsis-induced acute kidney injury through activating NF-kappaB mediated renal inflammatory responses","volume":"75","author":"Zhang","year":"2026","journal-title":"Physiol. Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120212_bb0140","doi-asserted-by":"crossref","first-page":"771","DOI":"10.62347\/MVRX1911","article-title":"Fasudil improves neutrophilic asthma by influencing M1 macrophage polarization and the expression of the NF-\u03baB\/TLR-2\/RPS3 pathway","volume":"18","author":"Guo","year":"2026","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbamcr.2026.120212_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144955","article-title":"A review on ribosomal protein S3 (RPS3): roles in cancer and its resistance to drugs","volume":"318","author":"Kim","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbamcr.2026.120212_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.804439","article-title":"RPS3 promotes the metastasis and cisplatin resistance of adenoid cystic carcinoma","volume":"12","author":"Rui","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120212_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.70076","article-title":"Ribosomal proteins in cell biology and cancer","volume":"5","author":"Zhang","year":"2026","journal-title":"MedComm \u2013 Oncology"},{"issue":"17","key":"10.1016\/j.bbamcr.2026.120212_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17172825","article-title":"Extra-ribosomal roles for ribosomal proteins and their relevance to tumour suppression, carcinogenesis and cancer progression","volume":"17","author":"Pk","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.bbamcr.2026.120212_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/genes13122183","article-title":"Mechanisms of EGFR-TKI-induced apoptosis and strategies targeting apoptosis in EGFR-mutated non-small cell lung cancer","volume":"13","author":"Nishihara","year":"2022","journal-title":"Genes (Basel)"},{"issue":"7","key":"10.1016\/j.bbamcr.2026.120212_bb0170","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.ccell.2026.05.020","article-title":"Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer","volume":"44","author":"Liao","year":"2026","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.bbamcr.2026.120212_bb0175","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/cac2.70068","article-title":"CD24 is a promising immunotherapeutic target for enhancing efficacy of third-generation EGFR-TKIs on EGFR-mutated lung cancer","volume":"45","author":"Liang","year":"2025","journal-title":"Cancer Commun. (Lond.)"},{"issue":"17","key":"10.1016\/j.bbamcr.2026.120212_bb0180","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa2503001","article-title":"Overall survival with amivantamab-lazertinib in EGFR-mutated advanced NSCLC","volume":"393","author":"Yang","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2026.120212_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218069","article-title":"Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma","volume":"634","author":"Huang","year":"2025","journal-title":"Cancer Lett."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926001114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926001114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:29:47Z","timestamp":1787646587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488926001114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0167488926001114"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120212","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LAPTM4B promotes gefitinib resistance and tumor stemness in non-small cell lung cancer by stabilizing RPS3 through inhibiting its ubiquitination","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120212"}}